MELD and MELD-Na: The Complete Guide to Liver Transplant Prioritisation
Dr. Sarah Mitchell
Interventional Cardiologist
MELD-Na replaced standard MELD for organ allocation in 2016. Understand the formula, the sodium correction, and how to use these scores to guide transplant listing decisions and predict 90-day waitlist mortality.
From TIPS to Transplant Allocation
The MELD score was originally developed to predict 3-month mortality after TIPS procedures. Its objectivity — using only laboratory values — made it far superior to the subjective Child-Pugh score for organ allocation. UNOS adopted MELD in 2002, and MELD-Na in 2016.
The MELD Formula
MELD = 9.57 × ln(Creatinine) + 3.78 × ln(Bilirubin) + 11.20 × ln(INR) + 6.43Creatinine is capped at 4.0 mg/dL. Patients on dialysis twice in the preceding week are automatically assigned creatinine = 4.0.
Why MELD-Na?
Hyponatraemia (serum sodium < 135 mEq/L) is independently associated with 2–3× increased 90-day waitlist mortality in cirrhosis. The MELD-Na formula:
MELD-Na = MELD + 1.32 × (137 − Na) − [0.033 × MELD × (137 − Na)]Sodium is capped at 125–137 mEq/L to prevent gaming by aggressive sodium correction.
Score Interpretation
| MELD-Na | 3-Month Mortality | Clinical Action |
|---|
| < 10 | ~2% | Outpatient monitoring |
| 10–14 | ~6% | Regular hepatology follow-up |
| 15–19 | ~20% | Transplant listing consideration |
| 20–29 | ~20–25% | Active transplant listing |
| 30–39 | ~50% | Priority listing |
| ≥ 40 | ~70% | Urgent allocation |
Practical Pearls
Do not aggressively correct hyponatraemia before listing — rapid sodium correction risks osmotic demyelination syndrome. Maximum correction: 8–10 mEq/L per 24 hours. MELD ≥ 15: Transplant listing benefits outweigh operative risk — this is the UNOS threshold for listing consideration. MELD does not capture portal hypertension complications (ascites, encephalopathy, variceal haemorrhage). Always use alongside clinical assessment. Hepatocellular carcinoma exception points: Patients with HCC within Milan criteria receive MELD exception points to account for tumour progression risk not captured by MELD.Child-Pugh vs. MELD
Child-Pugh remains useful for:
- •Surgical risk assessment
- •Drug dosing in liver disease
- •BCLC staging for HCC
- •Communication with patients (Class A/B/C is intuitive)
MELD-Na is preferred for:
- •Transplant waitlist prioritisation
- •Predicting 90-day mortality
- •Objective serial monitoring
Clinical Disclaimer
This article is intended for educational purposes and clinical decision support only. Always correlate with the individual patient's clinical context, institutional guidelines, and current evidence. ClinicalCalc Pro does not replace clinical judgment.
Tags